摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-甲氧基苯基)-2-甲基噻唑 | 50834-78-1

中文名称
4-(4-甲氧基苯基)-2-甲基噻唑
中文别名
——
英文名称
methyl 4-(2-methyl-1,3-thiazol-4-yl)phenyl ether
英文别名
4-(4-methoxyphenyl)-2-methylthiazole;4-(4-methoxy-phenyl)-2-methyl-thiazole;5-(4-methoxy-phenyl)-2-methyl-thiazole;4-(4-Methoxy-phenyl)-2-methyl-thiazol;5-(4-Methoxy-phenyl)-2-methyl-thiazol;4-(4-methoxyphenyl)-2-methyl-1,3-thiazole
4-(4-甲氧基苯基)-2-甲基噻唑化学式
CAS
50834-78-1
化学式
C11H11NOS
mdl
MFCD00460502
分子量
205.28
InChiKey
OVKCVKLSCKKRJY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    64-69℃

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.181
  • 拓扑面积:
    50.4
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934100090

SDS

SDS:f797bbf422c18b88e5320858db39a09c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-(4-Methoxyphenyl)-2-methylthiazole
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-(4-Methoxyphenyl)-2-methylthiazole
CAS number: 50834-78-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H11NOS
Molecular weight: 205.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS<br/>[FR] COMPOSES ET COMPOSITIONS SERVANT DE MODULATEURS PPAR
    申请人:IRM LLC
    公开号:WO2005116000A1
    公开(公告)日:2005-12-08
    The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families, particularly the activity of PPAR.
    这项发明提供了化合物,包括这些化合物的药物组合物,以及使用这些化合物来治疗或预防与过氧化物酶体增殖物激活受体(PPAR)家族的活性相关的疾病或紊乱的方法,特别是PPAR的活性。
  • Access to Thiazole via Copper-Catalyzed [3+1+1]-Type Condensation Reaction under Redox-Neutral Conditions
    作者:Xiaodong Tang、Jidan Yang、Zhongzhi Zhu、Meifang Zheng、Wanqing Wu、Huanfeng Jiang
    DOI:10.1021/acs.joc.6b02124
    日期:2016.11.18
    [3+1+1]-type condensation reaction from oximes, anhydrides and potassiumthiocyanate (KSCN) is developed herein. The transformation has good functional group tolerance and various thiazoles were formed smoothly in good to excellent yields under mild reaction conditions. This process involves copper-catalyzed N–O/C–S bond cleavages, activation of vinyl sp2 C–H bond, and C–S/C–N bond formations which are
    本文开发了通过,酸酐和硫氰酸钾(KSCN)的催化的[3 + 1 + 1]型缩合反应制备噻唑的新策略。该转化具有良好的官能团耐受性,并且在温和的反应条件下以良好至优异的收率顺利形成了各种噻唑。此过程涉及催化的N–O / C–S键断裂,乙烯基sp 2 C–H键的活化以及在氧化还原中性条件下的C–S / C–N键形成以及操作简便性。
  • [EN] BICYCLIC CARBOXYLATES AS MODULATORS OF TRANSPORTERS AND USES THEREOF<br/>[FR] CARBOXYLATES BICYCLIQUES UTILISÉS EN TANT QUE MODULATEURS DE TRANSPORTEURS ET LEURS UTILISATIONS
    申请人:NIROGY THERAPEUTICS INC
    公开号:WO2021061929A1
    公开(公告)日:2021-04-01
    The present invention generally relates to the field of transporter modulators, e.g., monocarboxylate transporter inhibitors, and more particularly to new bicyclic enone carboxylate compounds, the synthesis and use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with monocarboxylate transporter activity such as in treating cancer and other neoplastic disorders, tissue and organ transplant rejection.
    本发明通常涉及转运体调节剂领域,例如单羧酸转运体抑制剂,更具体地涉及新的双环烯酮羧酸酯化合物,这些化合物的合成和使用以及它们的药物组合物,例如在治疗、调节和/或预防与单羧酸转运体活性相关的生理状况,如治疗癌症和其他肿瘤性疾病、组织和器官移植排斥等方面的应用。
  • QUINUCLIDINE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
    申请人:Cook, II James H.
    公开号:US20090270405A1
    公开(公告)日:2009-10-29
    The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic α7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.
    该披露提供了公式I的化合物,包括它们的盐,以及使用这些化合物的组合物和方法。这些化合物是烟碱性α7受体的配体,可能对治疗中枢神经系统的各种疾病,特别是情感和神经退行性疾病,有用。
  • An Efficient, Catalyst- and Solvent-Free Synthesis of imidazo[1,2-<i>a</i>]pyridines and 2,4-disubstituted thiazoles on Grinding
    作者:Dongjian Zhu、Jiuxi Chen、Dengze Wu、Miaochang Liu、Jinchang Ding、Huayue Wu
    DOI:10.3184/030823409x401844
    日期:2009.2

    An efficient synthesis of imidazo[1,2- a]pyridines and 2,4-disubstituted thiazoles in excellent yield under catalyst-and solvent-free conditions at room temperature on grinding has been developed. The important features of this method are that it is reasonably fast, very clean, high yielding, simple workup and environmentally benign.

    在室温研磨、无催化剂和溶剂的条件下,开发出了一种高效合成咪唑并[1,2-a]吡啶和 2,4-二取代噻唑的方法,收率极高。该方法的重要特点是速度快、非常清洁、产率高、操作简单且对环境无害。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯